Please login to the form below
Abilify
The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Abilify was produced by Otsuka and Bristol-Myers Squibb.
Teva’s weak pipeline hit by Tourette’s drug trial failure
110 and Otsuka’s well-established antipsychotic drug Abilify (aripiprazole), which is in a trial with data due next year.
Four digital health trends set to reinvent and re-energise pharma
For example, Abilify MyCite is the first ‘digital medicine’ approved by the FDA in the US.
Lundbeck’s key products shine in Q2 but problems remain
Sales of Rexulti (brexpiprazole), Abilify Maintena (aripiprazole), Trintellix (vortioxetine) and Northera (droxidopa) increased by 20% to 44% in the quarter, resulting in overall sales of those key products coming in above
Indivior push to diversify boosted by schizophrenia drug approval
Perseris will face competition from Lundbeck/Otsuka’s Abilify Maintena and J&J’s Invega Sustenna. ... It will launch in competition to other monthly therapies, such as Lundbeck/Otsuka’s market leading Abilify Maintena (aripiprazole) and Johnson
First digital medicine approved in the US
The antipsychotic drug has a built-in digital tracking sensor. The FDA has approved Otsuka and Proteus Health’s Abilify MyCite, a pill with an embedded sensor that monitors whether patients ... Abilify MyCite is the latest iteration of antipsychotic
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
Featured jobs
- Senior Medical Writer or Lead Medical Writer
-
£Competitive Salary
-
Senior External Communications Lead
-
£Competitive Salary
- Account Director, Healthcare Communications
-
Salary TBC
-
Publications director
-
Competitive salary and bonus scheme
-
Account Director
-
£Competitive Salary
-
Account Director, Medical Education
-
Salary TBC
- Group Director of Medical Affairs and Scientific Strategy, Medic...
-
Substantial six figure package
-
Account director
-
Competitive salary and bonus scheme
-
Experienced medical editor
-
Competitive salary and bonus scheme
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
- Senior Medical Writer, MedComms Agency
-
Salary TBC
- Digital Associate Director - Medcomms
-
£65000 - £80000 per annum
-
Account Manager
-
£Competitive Salary
-
Scientific Director
-
£60000 - £85000 per annum, Benefits: Bonus, pension, subsidised gym and much more
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
-
Account Manager (PR)
-
Great Benefits
- Brand Manager - Medium Global Pharma Company
-
£Competitive Financial Package
Subscribe to our email news alerts
- Merck’s Ebola vaccine wins approval in four African countries
- US backs Sanofi’s ‘fast-track’ coronavirus vaccine
- Genital herpes vaccine candidate heads for human studies
- Bayer shares dip as Novartis gets EU okay for Beovu in wet AMD
- Categories - Communiqué Awards
- Researchers discover new antibiotic using AI
- Lilly’s Trulicity scores CV reduction indication in the US
- As new coronavirus outbreaks emerge, fears of a global pandemic escalate
- Introducing Nucleus POLAR™, a state-of-the-art external expert search engine and engagement management tool
- BMS scores first oesophageal cancer nod for Opdivo in Japan
- Esperion gets FDA thumbs up for cholesterol drug Nexletol
- Lundbeck gets US approval for migraine drug at heart of Alder takeover
PMHub
Skills in Healthcare
At Skills in Healthcare, we are able to provide our customers with a professional set of sales capabilities. With our...
Latest intelligence
- BRIC markets
- Why these countries offer an opportunity for pharma despite a slowdown...
- Obstetrics Virtual Journal Club: An Impetus Digital Customer Success Story
- Our online solutions are not just for advisory boards - find out how one client leveraged the Impetus InSite Platform® for a virtual journal club....
- Novo Nordisk awakens its ‘Sleeping Beauty’
- Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...
Quick links
Infographics
